Comments
Caplin Point Laboratories has said that Caplin Steriles (wholly-owned subsidiary) has been granted final approval by the USFDA for its Abbreviated New Drug Application (ANDA) Glycopyrrolate injection USP, 0.2mg/ml (in 1 ml, 2 ml, 5 ml and 20 ml vial presentations). The anticholinergic drug is a generic therapeutic equivalent version of Robinul from West-Ward Pharmaceuticals International Ltd. Shares of Caplin Point edged up 0.61 per cent at ₹405.95 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.